The results obtained in the present work suggest that pharmacological modulation of β1AR and A1R activity in cardiac cells could be a potential new strategy to reduce the incidence of severe arrhythmias and increase life expectancy in PD patients. This evidence concerns the gene ADRB1 and Arrhythmia.